Detalles de la búsqueda
1.
Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients.
J Viral Hepat
; 27(10): 1071-1081, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32384193
2.
Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma.
Cell Physiol Biochem
; 49(3): 1007-1018, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30196292
3.
The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients.
Gastroenterol Rep (Oxf)
; 9(4): 313-322, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34567563
4.
Efficacy and Safety of Sofosbuvir-Based Direct-Acting Antiviral Agents Treatment for Patients with Genotype 3/6 Hepatitis C Virus Infection.
Can J Gastroenterol Hepatol
; 2020: 8872120, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33194875
5.
Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma.
Biomed Res Int
; 2020: 3765937, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32626741
6.
Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China.
Stem Cells Int
; 2019: 4130757, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30863450
7.
Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients.
Aging (Albany NY)
; 10(11): 3450-3473, 2018 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481161
8.
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse.
Can J Gastroenterol Hepatol
; 2018: 1817680, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29862225
9.
Response to: Comment on "48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse".
Can J Gastroenterol Hepatol
; 2019: 2970510, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31187027
10.
What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?
World J Gastroenterol
; 18(33): 4604-9, 2012 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22969236
Resultados
1 -
10
de 10
1
Próxima >
>>